Xenon Pharmaceuticals Inc. | ||||
NGM : XENE || Location: Canada | ||||
$40.1+0.6 (+1.52%) |
0.25 M | 38.85 - 40.82 | ||
Last Updated:America/New_York | Volume | Day range |
Short Interest
Short Date | Short Interest |
---|---|
April 15, 2024 | 2.618 M |
March 28, 2024 | 2.756 M |
March 15, 2024 | 2.622 M |
Feb. 29, 2024 | 2.703 M |
Feb. 15, 2024 | 2.526 M |
EPS Surprise
Period | Estimate | Actual | Surprise |
---|---|---|---|
12/31/2023 | -0.77 | -0.64 | 17.36% |
09/30/2023 | -0.79 | -0.73 | 7.55% |
06/30/2023 | -0.71 | -0.72 | -1.22% |
03/31/2023 | -0.63 | -0.63 | 0.63% |
12/31/2022 | -0.60 | -0.57 | 4.46% |
Sector | Healthcare | Industry | Biotechnology |
Shares Outstanding | 75.432M | Shares Float | 69.561M |
Short Float | 2.618M | Market Cap | 2979.56M |
Institution ownership | 0.00% | Insider ownership | 0.377% |
Earnings Date | 05/07/2024 AMC | Cash Per Share | ? |
Trailing EPS | -2.73 | Forward EPS | -3.29 |